Compare RKDA & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKDA | BJDX |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Agricultural Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.8M |
| IPO Year | 2015 | 2021 |
| Metric | RKDA | BJDX |
|---|---|---|
| Price | $1.09 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.9K | 18.3K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 66.92 | ★ 86.65 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,858,000.00 | $249,040.00 |
| Revenue This Year | $61.67 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $0.63 |
| 52 Week High | $6.71 | $4.17 |
| Indicator | RKDA | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.33 | 38.75 |
| Support Level | $1.01 | $1.42 |
| Resistance Level | $1.26 | $2.10 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 15.38 | 2.42 |
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.